ISRG Stock Overview
Develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ISRG from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Intuitive Surgical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$552.41 |
| 52 Week High | US$616.00 |
| 52 Week Low | US$396.15 |
| Beta | 1.7 |
| 1 Month Change | 7.47% |
| 3 Month Change | -2.02% |
| 1 Year Change | 38.66% |
| 3 Year Change | 155.28% |
| 5 Year Change | 188.48% |
| Change since IPO | 27,424.93% |
Recent News & Updates
Intuitive Surgical: Moat, Resilience But High Market Expectations
May 28It Looks Like Shareholders Would Probably Approve Intuitive Surgical, Inc.'s (NASDAQ:ISRG) CEO Compensation Package
Apr 24
Recent updates
Intuitive Surgical: Moat, Resilience But High Market Expectations
May 28It Looks Like Shareholders Would Probably Approve Intuitive Surgical, Inc.'s (NASDAQ:ISRG) CEO Compensation Package
Apr 24Intuitive Surgical: Too Many Rain Clouds Coming
Apr 18Intuitive Surgical: Premium Valuation Meets Mounting Headwinds (Downgrade)
Apr 11
From Battle Field to Robotic Surgery
Intuitive Surgical (ISRG) is a pioneer in robotic-assisted surgery, revolutionizing the medical field with its da Vinci surgical system. Founded in 1995, the company has continuously innovated, making
Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth
Increased Adoption of Robotic Surgery:Hospitals and surgical centers continue to adopt Intuitive Surgical’s da Vinci systems as clinical evidence shows improved outcomes and reduced recovery times.ExpIntuitive Surgical: Getting Closed To Its Fair Value
Mar 09If EPS Growth Is Important To You, Intuitive Surgical (NASDAQ:ISRG) Presents An Opportunity
Mar 02Intuitive Surgical: The Robot Is Well-Oiled
Jan 28Intuitive Surgical: Second Half 2025 Guidance Is Critical To Maintaining Current Euphoria
Jan 20Intuitive Surgical (NASDAQ:ISRG) Hasn't Managed To Accelerate Its Returns
Jan 17Revenues Tell The Story For Intuitive Surgical, Inc. (NASDAQ:ISRG)
Dec 30Intuitive Surgical: Growing Impressively, But It Appears Overvalued
Dec 27Intuitive Surgical: One Of The Best Business Models In The World, But Not At This Price
Nov 14Intuitive Surgical Q3: Da Vinci 5 Robot Set For 2025, But Overvalued
Oct 18Intuitive Surgical (NASDAQ:ISRG) Is Reinvesting At Lower Rates Of Return
Oct 04Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns
Sep 24What You Can Learn From Intuitive Surgical, Inc.'s (NASDAQ:ISRG) P/S
Sep 16Intuitive Surgical: Detached From Fundamentals
Aug 26
Da Vinci 5 Launch And Digital Expansion Set To Revolutionize Surgical Efficiency And Drive Growth
Launch of da Vinci 5 systems and expansion in digital services like My Intuitive app show promise for revenue growth and operational efficiency.Intuitive Surgical: A Lofty Price To Pay For Innovation, Wait For A Better Entry Point
Aug 20There May Be Underlying Issues With The Quality Of Intuitive Surgical's (NASDAQ:ISRG) Earnings
Jul 26Intuitive Surgical: Shares Surge, But Now Near Fair Value (Rating Downgrade)
Jul 12Does Intuitive Surgical (NASDAQ:ISRG) Deserve A Spot On Your Watchlist?
Jul 11There Are Reasons To Feel Uneasy About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Jun 25What Is Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Share Price Doing?
Jun 10Intuitive Surgical: Sell Signals Abound
May 17Intuitive Surgical: Growth And Margins Will Be Challenged In 2024
Apr 12Intuitive Surgical: Buy A 'Little Slice' Of The Future
Jan 29Intuitive Surgical: Strong Pre-Announced Q4 - Time To Harvest The Gain, Initiate With 'Sell'
Jan 13Shareholder Returns
| ISRG | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.0% | 0.1% | 0.8% |
| 1Y | 38.7% | 9.6% | 11.5% |
Return vs Industry: ISRG exceeded the US Medical Equipment industry which returned 9.6% over the past year.
Return vs Market: ISRG exceeded the US Market which returned 11.5% over the past year.
Price Volatility
| ISRG volatility | |
|---|---|
| ISRG Average Weekly Movement | 6.9% |
| Medical Equipment Industry Average Movement | 9.2% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: ISRG has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ISRG's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 15,638 | Gary Guthart | www.intuitive.com |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.
Intuitive Surgical, Inc. Fundamentals Summary
| ISRG fundamental statistics | |
|---|---|
| Market cap | US$197.20b |
| Earnings (TTM) | US$2.48b |
| Revenue (TTM) | US$8.71b |
Is ISRG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ISRG income statement (TTM) | |
|---|---|
| Revenue | US$8.71b |
| Cost of Revenue | US$2.87b |
| Gross Profit | US$5.85b |
| Other Expenses | US$3.37b |
| Earnings | US$2.48b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.91 |
| Gross Margin | 67.09% |
| Net Profit Margin | 28.41% |
| Debt/Equity Ratio | 0% |
How did ISRG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/28 10:18 |
| End of Day Share Price | 2025/05/28 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Intuitive Surgical, Inc. is covered by 61 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| David Toung | Argus Research Company |
| Richard Purkiss | Atlantic Equities LLP |